PWS
ABMD

Peloton Wealth Strategists’s Abiomed Inc ABMD Stock Holding History

Peloton Wealth Strategists’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,485
Closed -$1.28M – 81
2019
Q4 		$1.28M Sell
7,485
-965
-11% -$179K 0.77% 50
2019
Q3 		$1.5M Buy
8,450
+3,095
+58% +$669K 0.96% 44
2019
Q2 		$1.4M Buy
+5,355
New +$1.42M 0.93% 46

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Peloton Wealth Strategists's ABMD Position: Q1 2020 in Review

Peloton Wealth Strategists sold out of Abiomed Inc (ABMD) in Q1 2020, closing a stake of 7,485 shares — an estimated $1.28M sold.

Peloton Wealth Strategists first reported a position in ABMD in Q2 2019 and held it in 3 quarters. The position peaked at $1.5M in Q3 2019. 412 funds tracked by Wall St. Rank hold ABMD as of Q1 2020.

  • Peloton Wealth Strategists reported no remaining Abiomed Inc position as of Q1 2020 after selling out during the quarter.
  • Peloton Wealth Strategists sold 7,485 Abiomed Inc shares in Q1 2020, an estimated $1.28M.
  • Peloton Wealth Strategists first reported a position in Abiomed Inc in Q2 2019 and held it in 3 quarters.
  • Peloton Wealth Strategists's Abiomed Inc position peaked at $1.5M in Q3 2019.
  • 412 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2020.

Based on Peloton Wealth Strategists's 13F filing for Q1 2020, filed 15 May 2020.